Skip to main content

New treatment options in castration-resistant prostate cancer.

Publication ,  Journal Article
Armstrong, AJ
Published in: J Natl Compr Canc Netw
May 2015

Most of the updates in the 2015 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer center on the systemic therapy front, with a host of newer agents in the mix. At the NCCN 20th Annual Conference, Dr. Andrew J. Armstrong discussed some of the key developments in metastatic castration-resistant and castration-sensitive prostate cancer, particularly the conflicting results on repurposing docetaxel in castration-sensitive disease, the specific population who may experience greater survival benefit from immunotherapy in castration-resistant disease, updated data on the use of androgen receptor and biosynthesis inhibitors, and the emerging role of AR-V7 (androgen-receptor splice variant 7 messenger RNA) as a biomarker of treatment response.

Duke Scholars

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

May 2015

Volume

13

Issue

5 Suppl

Start / End Page

690 / 693

Location

United States

Related Subject Headings

  • Taxoids
  • Receptors, Androgen
  • Randomized Controlled Trials as Topic
  • Prostatic Neoplasms, Castration-Resistant
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Drug Resistance, Neoplasm
  • Docetaxel
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J. (2015). New treatment options in castration-resistant prostate cancer. J Natl Compr Canc Netw, 13(5 Suppl), 690–693. https://doi.org/10.6004/jnccn.2015.0205
Armstrong, Andrew J. “New treatment options in castration-resistant prostate cancer.J Natl Compr Canc Netw 13, no. 5 Suppl (May 2015): 690–93. https://doi.org/10.6004/jnccn.2015.0205.
Armstrong AJ. New treatment options in castration-resistant prostate cancer. J Natl Compr Canc Netw. 2015 May;13(5 Suppl):690–3.
Armstrong, Andrew J. “New treatment options in castration-resistant prostate cancer.J Natl Compr Canc Netw, vol. 13, no. 5 Suppl, May 2015, pp. 690–93. Pubmed, doi:10.6004/jnccn.2015.0205.
Armstrong AJ. New treatment options in castration-resistant prostate cancer. J Natl Compr Canc Netw. 2015 May;13(5 Suppl):690–693.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

May 2015

Volume

13

Issue

5 Suppl

Start / End Page

690 / 693

Location

United States

Related Subject Headings

  • Taxoids
  • Receptors, Androgen
  • Randomized Controlled Trials as Topic
  • Prostatic Neoplasms, Castration-Resistant
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Drug Resistance, Neoplasm
  • Docetaxel